Home / Gabapentin / Belgium
BE ATC N02BF01 · updated 2 Nov 2026
Gabapentin shortage in Belgium
Is there a Gabapentin shortage in Belgium?
Yes. As of 2 Nov 2026, 6 Gabapentin products are reported short in Belgium, the first since 6 Aug 2026. The company estimate for the return is 20 Nov 2026 (latest 15 Mar 2027). Main reason: other.
Also short in Canada, Italy, Spain, Ireland, Austria, Czechia, Norway, Sweden. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Neurontin 800 mg (PI Pharma) film-coat. tabl. 90 | PI Pharma | 6 Aug 2026 | 30 Nov 2026 | Other Other reason |
| BE | Neurontin 800 mg film-coat. tabl. 90 | Viatris Healthcare | 12 Oct 2026 | 16 Dec 2026 | Manufacturing problem Delay in production |
| BE | Gabapentine Sandoz 300 mg hard caps. 200 | Sandoz | 16 Oct 2026 | 20 Nov 2026 | Other Other reason |
| BE | Neurontin 400 mg hard caps. 90 | Viatris Healthcare | 16 Oct 2026 | 30 Dec 2026 | Manufacturing problem Delay in production |
| BE | Gabapentine Teva 100 mg hard caps. 200 | Teva | 27 Oct 2026 | 15 Mar 2027 | Manufacturing problem Delay in production |
| BE | Neurontin 600 mg (PI Pharma) film-coat. tabl. 90 | PI Pharma | 29 Oct 2026 | 31 Dec 2026 | Other Other reason |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.